Programme

Saturday 5th September

15:00 to 16:30

Access to Medicines-Sanofi Satellite Symposium

Title: ACCESS TO CARE FOR EPILEPSY IN EMERGING COUNTRIES: DRIVING THE PARADIGM SHIFT

Co-chairs: Candan Gürses (Turkey) & Michel Dumas (France)

Developing access to care for people with epilepsy in emerging countries: a review of the literature - Pierre-Marie Preux (France)

Educating and fighting stigma in Ethiopian schools: results of a Knowledge Attitude Practice study -Redda Tekle Haimanot (Ethiopia)

Empowering primary healthcare professionals in Peru to diagnose and manage people with epilepsy - Alberto Diaz (Peru)

Influencing policies through advocacy in the Buenos Aires Province - Brenda Giagante (Argentina)

Developing access to healthcare: what role for the pharmaceutical industry? - Daniel Gérard (France)

 
Cyberonics Satellite Symposium

Title: Treating drug-resistant epilepsy: Why are we waiting?

Chair: Paul Boon (Belgium)

Introduction: The drug-resistant epilepsy (DRE) treatment gap - Paul Boon (Belgium)

Risks beyond seizures - Philippe Ryvlin (Switzerland)

Defining treatment success in difficult-to-manage epilepsy - James Wheless (USA)

Closing the treatment gap in DRE: A Japanese success story - Kensuke Kawai (Japan)

Interactive debate: Why are we waiting so long to treat DRE? - Panel and audience

 

Sunday 6th September

07:00 to 09:00

Matthew's Friends Morning Symposium

Title: KETOGENIC DIETARY THERAPIES FROM INFANCY TO ADULTHOOD

Chair: Helen Cross (United Kingdom)

Clinical Research supporting the use of Ketogenic Dietary Therapies for epilepsy and other neurological conditions. Overview of new and ongoing research projects for Ketogenic Dietary Therapies - Helen Cross (United Kingdom)

Use of Ketogenic Dietary Therapies in infants and children. Contraindications to the use of Ketogenic Dietary Therapy. Drug Interactions with Ketogenic Therapy - Ingrid Scheffer (Australia)

Using Ketogenic Dietary Therapies in adults & how it differs from its use in children. ILAE Task Force for Dietary Therapies in Epilepsy overview including setting up a service in resource strapped areas - Eric Kossoff (USA)

The Mediterranean Ketogenic Diet in Turkey. Setting up a service and the treatment of patients -Orkide Guzel (Turkey)

Supporting families and patients using ketogenic dietary therapies to enhance compliance to the treatment. The Matthew’s Friends Charity for Ketogenic Dietary Therapies - Emma Williams (United Kingdom)

 

17:30 to 19:00

UCB Satellite Symposium - TBC

Title: One Size Does Not Fit All: A Tailored Approach to the Management of Epilepsy

Chair: Candan Gürses (Turkey)

Cognitive vulnerability in patients with epilepsy: consequences of disease and treatment - Albert Aldenkamp (Netherlands)

How is choice of technology improving outcomes after surgery for patients with epilepsy? -  Andrew McEvoy (United Kingdom)

Epilepsy in the older adult: current management and treatment trends - Eugen Trinka (Austria)

 

Monday 7th September

07:30 to 09:00

Elekta Morning Symposium

Title: ADVANCES IN FUNCTIONAL MAPPING AND LOCALIZATION OF THE EPILEPTOGENIC ZONE

Chair: Hermann Stefan (Germany)

What is MEG, the basics? - Hermann Stefan (Germany)

What is source imaging and why is it important in clinical epilepsy work? - Sandor Beniczky (Denmark)

What does MEG contribute to the management of adult epilepsy patients? - Stefan Rampp (Germany)

The role of MEG in children with epilepsy? - Patrick Van Bogaert (Belgium)

What is the European MEG Society, EMEGS, and what can it do for you?- Paul Boon (Belgium)

 

17:30 to 19:00

Shire Satellite Symposium

Title: Shire International:  Management of prolonged, acute, convulsive seizures: What we learnt from the PERFECT™ Initiative

Chair: Lieven Lagae (Belgium)

Introduction and opening remarks - Lieven Lagae (Belgium)

How effective is the guidance and training for managing prolonged, acute, convulsive seizures in the community? - Alexis Arzimanoglou (France)

Patients with prolonged, acute, convulsive seizures and their carers: Experiences with rescue medication - Federico Vigevano (Italy)

The UK experience: does it reflect the findings from the PERFECT™ Initiative? - Fenella Kirkham (United Kingdom)

Panel discussion - All

Closing remarks - Lieven Lagae (Belgium)